triamterene has been researched along with Leishmania Infection in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tulloch, LB | 1 |
| Martini, VP | 1 |
| Iulek, J | 1 |
| Huggan, JK | 1 |
| Lee, JH | 1 |
| Gibson, CL | 1 |
| Smith, TK | 1 |
| Suckling, CJ | 1 |
| Hunter, WN | 1 |
1 other study available for triamterene and Leishmania Infection
| Article | Year |
|---|---|
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major | 2010 |